Literature DB >> 6181927

Antigenic variants of rabies virus.

L G Schneider.   

Abstract

Monoclonal antibodies directed either against the nucleocapsid or the glycoprotein of rabies virus were reacted by indirect immunofluorescence and mouse neutralization tests with vaccine strains and rabies field isolates of various origin. Major antigenic determinants allow the grouping of viruses and minor ones the differentiation of virus strains. A protection study showed the existence in nature of certain antigenic variants against which conventional vaccines do not fully protect. The isolation of two such variants from 'imported' bats in the Federal Republic of Germany is reported here for the first time.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6181927     DOI： 10.1016/0147-9571(82)90021-2

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN： 0147-9571            Impact factor:   2.268


  9 in total

1.  Antigenic variants of rabies virus in isolates from eastern, central and northern Canada.

Authors:  W A Webster; G A Casey; K M Charlton; T J Wiktor
Journal:  Can J Comp Med       Date:  1985-04

2.  Quantifying antigenic relationships among the lyssaviruses.

Authors:  D L Horton; L M McElhinney; D A Marston; J L N Wood; C A Russell; N Lewis; I V Kuzmin; R A M Fouchier; A D M E Osterhaus; A R Fooks; D J Smith
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

3.  Chimeric lyssavirus glycoproteins with increased immunological potential.

Authors:  C Jallet; Y Jacob; C Bahloul; A Drings; E Desmezieres; N Tordo; P Perrin
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

4.  Antigenic and molecular characterization of bat rabies virus in Europe.

Authors:  H Bourhy; B Kissi; M Lafon; D Sacramento; N Tordo
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

5.  T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination.

Authors:  M Herzog; C Fritzell; M Lafage; J A Montaño Hirose; D Scott-Algara; M Lafon
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

6.  Cross-protection of mice against a global spectrum of rabies virus variants.

Authors:  D L Lodmell; J S Smith; J J Esposito; L C Ewalt
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

Review 7.  The application of monoclonal antibodies in the study of viruses.

Authors:  M J Carter; V ter Meulen
Journal:  Adv Virus Res       Date:  1984       Impact factor: 9.937

Review 8.  Rabies in Costa Rica - Next Steps Towards Controlling Bat-Borne Rabies After its Elimination in Dogs.

Authors:  Bernal León; Silvia Fallas González; Lisa Miranda Solís; Manuel Ramírez-Cardoce; Andres Moreira-Soto; Juan M Cordero-Solórzano; Sabine Elisabeth Hutter; Rocío González-Barrientos; Charles E Rupprecht
Journal:  Yale J Biol Med       Date:  2021-06-30

9.  Abandon of intramuscular administration of rabies immunoglobulin for post-exposure prophylaxis in the revised guidelines in the Netherlands in 2018: cost and volume savings.

Authors:  Imke Schreuder; Cornelis De Pijper; Rob van Kessel; Leo Visser; Hans van den Kerkhof
Journal:  Euro Surveill       Date:  2020-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.